HALO - Halozyme Therapeutics Inc. (HALO) CEO Helen Torley on Q1 2019 Results - Earnings Call Transcript
Halozyme Therapeutics, Inc. (HALO)
Q1 2019 Earnings Conference Call
May 07, 2019, 16:30 ET
Company Participants
Albert Kildani - VP, IR & Corporate Communications
Laurie Stelzer - SVP & CFO
Helen Torley - President, CEO & Director
Dimitrios Chondros - Chief Medical Officer & SVP
Conference Call Participants
James Birchenough - Wells Fargo Securities
Jason Butler - JMP Securities
Daniel Wolle - JPMorgan Chase & Co.
Arlinda Lee - Canaccord Genuity
Joel Beatty - Citigroup
Pete Stavropoulos - Cantor Fitzgerald & Co.
Joseph Catanzaro - Piper Jaffray Companies
Presentation
Operator
Good afternoon, everyone. I would